Mori K, Ishida T, Yasuda T, et al. Serum Trans-Fatty Acid Concentration Is Elevated in Young Patients With Coronary Artery Disease in Japan. Circ J. 2015;79 (9) :2017-25.
Oshita T, Toh R, Shinohara M, et al. Elevated Serum Elaidic Acid Predicts Risk of Repeat Revascularization After Percutaneous Coronary Intervention in Japan. Circ J. 2019;83 (5):1032-8.
Honda T, Ohara T, Shinohara M, et al. Serum elaidic acid concentration and risk of dementia: The Hisayama Study. Neurology. 2019;93 (22) :e2053-e64.
Yokoyama M, Origasa H, Matsuzaki M, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS) : a randomised open-label, blinded endpoint analysis. Lancet. 2007;369 (9567) :1090-8.
Bhatt DL, Steg PG, Miller M, et al. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. N Engl J Med. 2019;380 (1) :11-22.